This new revolutionary product–a carbon monoxide pulse oximeter– comes from Masimo. From the press release:
Masimo Rainbow SET employs revolutionary sensor, hardware and software designs that are able to collect more information noninvasively than previously believed possible. With the introduction of Masimo SET® (Signal Extraction Technology) in 1996, Masimo solved the problem clinicians faced with inaccuracy and false alarms associated with pulse oximetry due to patient motion, low perfusion and other challenging conditions. Now, with Masimo Rainbow SET, Masimo ushers a new era where carbon monoxide and potentially other vital parameters can be safely and accurately monitored continuously and noninvasively.
In addition to Rainbow SET’s current ability to noninvasively monitor the level of carbon monoxide in the blood, Masimo’s engineering team is utilizing the additional data delivered by the Rainbow technology platform and sensors to qualify and document an array of new potential measurements and applications. The Masimo Rainbow SET platform has been developed with the intent to deliver accurate monitoring of parameters like methemoglobin (SpMet™), and fractional arterial oxygen saturation (SpaO2™), all measured noninvasively.
WOW! WOW! (I can hardly hold my excitement!) Potentially deadly carbon monoxide poisoning is notoriously difficult to diagnose: patient’s hemoglobin molecules cannot bind to oxygen, and the standard pulse oximeter is reading 100% saturation–simply unable to differentiate between oxygen and carbon monoxide. This is a major new product, bound to save countless lives.
More at Masimo…
